FOLFIRINOX Chemotherapy in Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis of Retrospective and Phase II Studies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FOLFIRINOX Chemotherapy in Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis of Retrospective and Phase II Studies
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 7, Issue 1, Pages 7
Publisher
MDPI AG
Online
2018-01-05
DOI
10.3390/jcm7010007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of FOLFIRINOX as second-line chemotherapy for metastatic pancreatic cancer after gemcitabine-based chemotherapy failure
- (2017) Noritoshi Kobayashi et al. MEDICINE
- FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience
- (2016) Muralidharan K Chllamma et al. BRITISH JOURNAL OF CANCER
- Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer
- (2016) Stacey M Stein et al. BRITISH JOURNAL OF CANCER
- Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse
- (2016) A. Orlandi et al. Clinical & Translational Oncology
- Improvement in advanced pancreatic cancer survival with novel chemotherapeutic strategies – experience of a community based hospital
- (2016) A. Hann et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer: A Single Centre Cohort Study
- (2016) SJ Rombouts et al. Journal of Cancer
- Clinical Insights Into the Biology and Treatment of Pancreatic Cancer
- (2016) Niharika B. Mettu et al. Journal of Oncology Practice
- Metastatic Pancreatic Carcinoma and Experience with FOLFIRINOX - a Cross Sectional Analysis From a Developing Country
- (2015) Muhammad Nauman Zahir et al. Asian Pacific Journal of Cancer Prevention
- Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer
- (2014) Takuji Okusaka et al. CANCER SCIENCE
- FOLFIRINOX for Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: The Royal Marsden Experience
- (2014) Sing Yu Moorcraft et al. Clinical Colorectal Cancer
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modified FOLFIRINOX Regimen With Improved Safety and Maintained Efficacy in Pancreatic Adenocarcinoma
- (2013) Hemchandra Mahaseth et al. PANCREAS
- FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity
- (2012) Krishna S. Gunturu et al. MEDICAL ONCOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started